What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?

Mototsugu Oya, Masaru Murai

研究成果: Article査読

抄録

The impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (RCC) is discussed herein with consideration of prolonged survival and quality of life. A nephrectomy can be indicated in a patient with good performance status and pulmonary metastases when adjuvant immunotherapy is an option. In contrast, in a patient with poor performance status and/or metastases including multiple organs, a nephrectomy is not indicated. To relieve symptoms, options other than nephrectomy should be considered.

本文言語English
ページ(範囲)1732-1737
ページ数6
ジャーナルGan to kagaku ryoho. Cancer & chemotherapy
29
10
出版ステータスPublished - 2002 10

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

フィンガープリント 「What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル